House Democrats Start Multiple Sclerosis Drug Price Probe

House Democrats have started what they called an "in-depth" investigation into the pricing of drugs for neurological condition multiple sclerosis, the latest attempt by U.S. politicians to pressure manufacturers to lower costs.

Seven drugmakers--Biogen, Sanofi, Novartis, Roche Holding, Bayer, Merck KGaA's EMD Serono unit and Teva Pharmaceuticals--received letters requesting information on pricing strategies from Elijah Cummings and Peter Welch, two representatives who sit on the House...

What feeling does this article give you?

#hashtags to follow:

House Democrats [+]    Biogen [+]    Sanofi [+]    Novartis [+]    Roche Holding [+]    Bayer [+]    Merck KGaA [+]    EMD Serono [+]    Teva Pharmaceuticals [+]   

More #news: